Mannin Research Overview

  • Founded
  • 2012
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $5.7M
Latest Deal Amount
  • Investors
  • 2

Mannin Research General Information

Description

Operator of a biotechnology company intended to focus on the discovery, research, development, and commercialization of therapeutics for vascular diseases. The company leverages a novel mechanism of action targeting the Tie2 mechanism of action through a diverse pipeline of new drugs and therapeutics, enabling the medical professionals to treat a wide spectrum of vascular-related diseases such as open-angle glaucoma, infectious disease, and acute kidney injury.

Contact Information

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Q BioMed
Primary Office
  • 629 Eastern Avenue
  • Suite C300
  • Toronto, Ontario M4M 1E4
  • Canada
+1 (416) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mannin Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 05-Nov-2019 $5.7M Completed Pre-Clinical Trials
3. Accelerator/Incubator 02-Feb-2017 Completed Pre-Clinical Trials
2. Accelerator/Incubator Completed Pre-Clinical Trials
1. Merger/Acquisition 13-Jan-2016 Completed Pre-Clinical Trials
To view Mannin Research’s complete valuation and funding history, request access »

Mannin Research Executive Team (4)

Name Title Board Seat Contact Info
George Nikopoulos Ph.D Chief Executive Officer and President
Susan Quaggin Chief Scientific Officer & Board Member
Doris Qamar Executive
Geoffrey Smith Secretary of the Board of Directors
To view Mannin Research’s complete executive team members history, request access »

Mannin Research Board Members (3)

Name Representing Role Since
Christopher Smith Self Chairman 000 0000
Geoffrey Smith Mannin Research Secretary of the Board of Directors 000 0000
Susan Quaggin Mannin Research Chief Scientific Officer & Board Member 000 0000
To view Mannin Research’s complete board members history, request access »

Mannin Research Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mannin Research Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Matter Accelerator/Incubator 000 0000 000000 0
To view Mannin Research’s complete investors history, request access »